20-63305931-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The ENST00000358894.11(COL20A1):c.388G>A(p.Gly130Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000089 in 1,460,528 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000358894.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL20A1 | NM_020882.4 | c.388G>A | p.Gly130Ser | missense_variant | 5/36 | ENST00000358894.11 | NP_065933.2 | |
COL20A1 | XM_011528937.2 | c.388G>A | p.Gly130Ser | missense_variant | 5/36 | XP_011527239.1 | ||
COL20A1 | XM_011528938.2 | c.388G>A | p.Gly130Ser | missense_variant | 5/36 | XP_011527240.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL20A1 | ENST00000358894.11 | c.388G>A | p.Gly130Ser | missense_variant | 5/36 | 1 | NM_020882.4 | ENSP00000351767 | P2 | |
COL20A1 | ENST00000479501.5 | n.450G>A | non_coding_transcript_exon_variant | 5/36 | 1 | |||||
COL20A1 | ENST00000422202.5 | c.388G>A | p.Gly130Ser | missense_variant | 4/35 | 5 | ENSP00000414753 | A2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247312Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134630
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1460528Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726556
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at